Article
Ribonucleotide Reductase Inhibition Triggers Ferroptosis in Genetically Defined Subsets of Non-Small Cell Lung Cancer.
Cancer research communications - 1 Sept 2026
Sen Utsav, Natour Dalia, Chakraborty Subhamoy, Gobbini Elisa, Fan Chih-Wei, Koelbel Calvin, Elliott Andrew, Vanderwalde Ari M, Borghaei Hossein, Halmos Balazs, Demircioglu Deniz, Hasson Dan, Gandhi Nishant, Sen Triparna
Abstract excerpt
Non-small cell lung cancer (NSCLC) is responsible for the majority of cancer-related mortality worldwide. Lung adenocarcinoma is the most common NSCLC subtype. Despite advances in targeted therapies, treatment resistance remains a critical challenge. Ribonucleotide reductase (RNR), a crucial enzyme in deoxyribonucleotide triphosphate biosynthesis, is frequently upregulated in cancer, contributing to genomic...
Read the complete abstract on PubMedTopics
- Humans
- Lung Neoplasms
- Ferroptosis
- Carcinoma, Non-Small-Cell Lung
- Ribonucleoside Diphosphate Reductase
